Search for content, post, videos

Acesion Pharma recruits new CFO

acesion-pharma

Acesion Pharma, a Danish biotech company developing novel treatments for atrial fibrillation (AF), announced that it has recruited Jakob Dynnes Hansen as its Chief Financial Officer to succeed Herik Moltke, who will continue as CFO of Scandinavian Micro Biodevices that was recently acquired by Zoetis.

Jakob joins Acesion from Evolva, a Swiss biotech company, where he has been CFO since 2007 and where he played a key role in the company’s public listing in 2009 and subsequent public financings. Prior to that Jakob was CFO of Nuevolution A/S and Zealand Pharma A/S and had senior roles at a Scandinavian investment bank and at Novo Nordisk A/S. Jakob will also continue to perform srvices for Evolva while the company is transitioning to a new CFO.

Advertisement